GTII Stock Overview
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for GTII from our risk checks.
Green Thumb Industries Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$15.32 |
52 Week High | CA$21.50 |
52 Week Low | CA$9.09 |
Beta | 1.45 |
11 Month Change | 0.13% |
3 Month Change | -11.70% |
1 Year Change | 65.62% |
33 Year Change | -57.69% |
5 Year Change | 42.78% |
Change since IPO | 71.17% |
Recent News & Updates
Recent updates
Green Thumb Industries Inc. Just Recorded A 174% EPS Beat: Here's What Analysts Are Forecasting Next
May 11Green Thumb Industries Inc. (CSE:GTII) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Apr 12Green Thumb Industries Inc.'s (CSE:GTII) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 28Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Feb 29Subdued Growth No Barrier To Green Thumb Industries Inc.'s (CSE:GTII) Price
Dec 19Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 31Green Thumb Industries (CSE:GTII) Takes On Some Risk With Its Use Of Debt
May 28These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Feb 27With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Feb 05Green Thumb Industries (CSE:GTII) Seems To Use Debt Quite Sensibly
Nov 27If EPS Growth Is Important To You, Green Thumb Industries (CSE:GTII) Presents An Opportunity
Oct 17Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 09With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Jul 19Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Apr 23Earnings Tell The Story For Green Thumb Industries Inc. (CSE:GTII)
Mar 03Green Thumb Industries (CSE:GTII) Has A Pretty Healthy Balance Sheet
Dec 24These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Sep 18Here's Why Green Thumb Industries Inc.'s (CSE:GTII) CEO May Deserve A Raise
Jun 21We Think That There Are Issues Underlying Green Thumb Industries' (CSE:GTII) Earnings
Mar 25Results: Green Thumb Industries Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Calculating The Intrinsic Value Of Green Thumb Industries Inc. (CSE:GTII)
Mar 08Shareholder Returns
GTII | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 3.5% | 7.2% | 2.8% |
1Y | 65.6% | 43.9% | 14.9% |
Return vs Industry: GTII exceeded the Canadian Pharmaceuticals industry which returned 43.9% over the past year.
Return vs Market: GTII exceeded the Canadian Market which returned 14.9% over the past year.
Price Volatility
GTII volatility | |
---|---|
GTII Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 10.4% |
Market Average Movement | 8.0% |
10% most volatile stocks in CA Market | 16.8% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: GTII has not had significant price volatility in the past 3 months.
Volatility Over Time: GTII's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 4,500 | Ben Kovler | www.gtigrows.com |
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.
Green Thumb Industries Inc. Fundamentals Summary
GTII fundamental statistics | |
---|---|
Market cap | CA$3.61b |
Earnings (TTM) | CA$89.65m |
Revenue (TTM) | CA$1.52b |
40.3x
P/E Ratio2.4x
P/S RatioIs GTII overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GTII income statement (TTM) | |
---|---|
Revenue | US$1.11b |
Cost of Revenue | US$537.64m |
Gross Profit | US$571.94m |
Other Expenses | US$506.43m |
Earnings | US$65.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.28 |
Gross Margin | 51.55% |
Net Profit Margin | 5.90% |
Debt/Equity Ratio | 17.7% |
How did GTII perform over the long term?
See historical performance and comparison